Philadelphia Business Journal Article: Main Line biotech firm advancing technology to help diagnose, treat prostate cancer
New Article on ProstaGene in the Philadelphia Business Journal from Senior Reporter John George:
A Montgomery County biotechnology company has raised $400,000 from private investors.
ProstaGene, which is based at the Lankenau Institute for Medical Research in Wynnewood, Pa., has developed a gene-based technology to help guide treatment decisions for patients with a type of cancer where immediate treatment is not always recommended.
ProstaGene is developing gene-based technology to diagnose and treat prostate cancer.